Digital MCMs

Empowering people to respond to health security threats through rapidly deployable digital health tools

Join Program

OVERVIEW

Digital health tools — digital countermeasures — can provide an important first line of defense to augment traditional medical countermeasures in the face of health security threats. Through this program, DRIVe is seeking simple, rapidly deployable, and equitably accessible digital health tools for diagnosis and risk assessment.

PARTNERS

Companies we have partnered with on this program to date


APPROACH

Develop novel digital technologies that accelerate the response to health security threats. Proposed solutions should increase access, reduce cost, or more rapidly disseminate medical countermeasures, such as diagnosis and risk assessment capabilities, by:

  • Capitalizing on broadly available and easily accessible digital platforms such as smartphones and web applications and/or
  • Combining novel analytic approaches, such as AI/ML, with broadly accessible data sources such as images, audio, sensors, or user data from smartphones/wearable devices; or other novel digital data sources.

Digital health tools include smartphone, web, and telehealth applications, data sets, or algorithms that are deployable on commonly available digital devices.

Program Goals

Establish a Suite of Digital Diagnostic Tools

To provide an accelerated response to health security threats

Demonstrate Utility of Non Traditional Data Sources

To enhance our understanding of health security threats and the efficacy of MCM

Evaluate Novel Data Analytics Approaches

To offer new solutions that augment traditional medical countermeasures

DIGITAL MCMs

Funding
Opened

8/25/21

Amendment

#14

Get PDF

Revised AOI
Description

1/7/2022

Amendment

#18

Get PDF

Revised AOI
Description

10/28/2022

Amendment

#001

Get PDF

Funding
Closes

2/3/24

Related Publications

CVS Health study captures emergence of SARS-CoV-2 variants

A CVS Health study conducted by its Clinical Trial Services organization under contract to the US Department of Health and Human Services provided early insights and signals...

BARDA DRIVe evolves its ENACT program into two areas of disruptive technology development of purely digital health tools...

ARDA's Division of Research, Innovation, and Ventures (DRIVE) today expanded the Early Notification to Act, Control, and Treat (ENACT) program to drive disruptive technologies needed to...

Looking for General FAQ?

Digital MCMs is open until Feb 3, 2024.